查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423333

2024-2032 年荷爾蒙替代療法市場報告（按產品、給藥途徑、疾病類型和地區）

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年全球荷爾蒙替代療法市場規模達91億美元。展望未來， IMARC Group預計到2032年市場規模將達到151億美元，2024-2032年複合年成長率（CAGR）為5.5%。荷爾蒙失調盛行率的上升、對荷爾蒙替代療法的認知和接受度的提高、老年人口的擴大、重大的技術進步和給藥方法的持續創新、政府的支持性舉措和報銷政策是推動該行業的一些主要因素。

荷爾蒙替代療法（HRT）是一種用於解決個別荷爾蒙失衡的醫療方法。它涉及施用外源激素來補充或取代體內自然產生的激素。 HRT 通常由內分泌科醫生或婦科醫生等醫療保健專業人員在徹底評估患者的病史和症狀後開立。透過持續提供受控劑量的激素，激素替代療法旨在減輕與激素缺乏或波動相關的症狀。治療過程受到密切監測，以確保維持最佳的荷爾蒙水平，從而促進整體健康並可能減輕荷爾蒙失衡的不利影響。

HRT 產業主要是由全球人口中荷爾蒙失衡和相關疾病日益流行所推動的。久坐的生活方式、壓力和老化等多種因素都會導致荷爾蒙波動，因此需要進行治療介入。此外，患者和醫療保健專業人員對 HRT 作為有效治療選擇的認知和接受程度不斷提高，這有助於市場擴張。除此之外，不斷擴大的老年人口是 HRT 市場成長的重要推手。隨著年齡的成長，荷爾蒙失衡變得更加普遍，導致對荷爾蒙替代療法的需求更高。除此之外，荷爾蒙輸送方法（例如經皮貼片和植入式設備）不斷取得的技術進步，提供了方便和有針對性的荷爾蒙管理，提高了患者的依從性和整體治療效果，正在加強市場的成長。此外，旨在確保患者能夠負擔得起 HRT 的支持性政府舉措和有利的報銷政策為市場提供了有利可圖的成長機會。

荷爾蒙替代療法市場趨勢/促進因素：

荷爾蒙失衡疾病的盛行率不斷增加

更年期、甲狀腺功能減退和生長激素缺乏等荷爾蒙失衡疾病在世界各地變得越來越普遍。這種上升可歸因於多種因素，如久坐的生活方式、壓力、環境因素和人口老化。因此，對荷爾蒙替代療法（HRT）來控制這些疾病症狀的需求不斷成長。除此之外，醫療保健提供者認知到需要解決荷爾蒙失衡問題並改善受影響個體的生活品質。結果，荷爾蒙替代療法的處方和使用激增。這些療法旨在透過以外源性來源補充或取代缺乏的荷爾蒙來恢復荷爾蒙平衡，減輕症狀並改善整體健康結果。

老年人口不斷增加

不斷擴大的老年人口是各領域市場成長的重要推動力，包括醫療保健產業，特別是 HRT 市場。隨著老年人口的持續成長，荷爾蒙失衡和需要醫療干預的相關疾病的盛行率不斷增加。隨著衰老，身體會經歷自然的生理變化，包括荷爾蒙產生和調節的下降。荷爾蒙失衡，包括與女性更年期和男性更年期相關的荷爾蒙失衡，變得更加普遍。這些不平衡可能導致一系列症狀和健康併發症，嚴重影響老年人的生活品質。 HRT 提供了一種透過補充或取代缺乏的荷爾蒙來恢復荷爾蒙平衡的解決方案，從而減輕症狀並改善整體健康。

激素輸送方法的重大技術進步

持續的技術進步是 HRT 領域市場成長的重要動力。這些進步在改善治療選擇、增強患者體驗和擴大 HRT 的覆蓋範圍方面發揮著至關重要的作用。技術創新促進了 HRT 新配方和給藥方法的開發，例如經皮貼片、皮下植入劑和凝膠配方，有助於市場擴張。此外，醫療保健領域的重大進步促進了 HRT 個人化醫療方法的發展。借助基因檢測和荷爾蒙水平監測等先進診斷技術，醫療保健提供者可以根據患者的具體需求量身定做 HRT 方案，確保最佳的荷爾蒙平衡並最大限度地減少副作用。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球荷爾蒙替代療法市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 價格分析
  • 市場區隔：按產品
  • 市場區隔：依給藥途徑
  • 市場區隔：依疾病類型
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：依產品

  • 雌激素替代療法
    • 市場走向
    • 市場預測
  • 人類生長激素替代療法
    • 市場走向
    • 市場預測
  • 甲狀腺替代療法
    • 市場走向
    • 市場預測
  • 睾酮替代療法
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依管理途徑

  • 口服
    • 市場走向
    • 市場預測
  • 注射用
    • 市場走向
    • 市場預測
  • 經皮
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依疾病類型

  • 停經
    • 市場走向
    • 市場預測
  • 甲狀腺功能低下症
    • 市場走向
    • 市場預測
  • 男性性腺功能減退症
    • 市場走向
    • 市場預測
  • 生長激素缺乏
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Bayer AG
    • Eli Lilly & Company
    • Roche
    • Hisamitsu Pharmaceutical Co. Inc.
    • Merck
    • Mylan NV
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
Product Code: SR112024A929

Abstract

The global hormone replacement therapy market size reached US$ 9.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The rising prevalence of hormonal disorders, increased awareness and acceptance of HRT, expanding geriatric population, significant technological advancements and ongoing innovations in delivery methods, supportive government initiatives and reimbursement policies are some of the major factors propelling the industry.

Hormone replacement therapy (HRT) is a kind of medical treatment utilized to address hormonal imbalances in individuals. It involves the administration of exogenous hormones to supplement or replace the naturally occurring hormones within the body. HRT is typically prescribed by healthcare professionals, such as endocrinologists or gynecologists, after a thorough evaluation of the patient's medical history and symptoms. By continuously providing a controlled dosage of hormones, HRT aims to alleviate symptoms associated with hormonal deficiencies or fluctuations. The treatment is closely monitored to ensure optimal hormone levels are maintained, thus promoting overall well-being and potentially mitigating the adverse effects of hormonal imbalances.

The HRT industry is primarily driven by the increasing prevalence of hormonal imbalances and related disorders among the global population. Various factors, such as sedentary lifestyles, stress, and aging, contribute to hormonal fluctuations, necessitating the need for therapeutic intervention. Moreover, the escalating awareness and acceptance of HRT as an effective treatment option among patients and healthcare professionals are aiding in market expansion. Besides this, the expanding geriatric population is acting as a significant growth-inducing driver of the HRT market. With age, hormonal imbalances become more prevalent, leading to a higher demand for HRT. In addition to this, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, providing convenient and targeted administration of hormones, improving patient compliance and overall treatment outcomes are strengthening the market growth. Furthermore, supportive government initiatives and favorable reimbursement policies aimed to ensure affordable access to HRT for patients are presenting remunerative growth opportunities for the market.

Hormone Replacement Therapy Market Trends/Drivers:

Increasing prevalence of hormonal imbalance disorders

Hormonal imbalance disorders such as menopause, hypothyroidism, and growth hormone deficiency are becoming increasingly common worldwide. This rise can be attributed to various factors such as sedentary lifestyles, stress, environmental factors, and an aging population. As a result, there is a growing demand for HRT to manage the symptoms of these disorders. In addition to this, healthcare providers are recognizing the need to address hormonal imbalances and improve the quality of life for affected individuals. As a result, there has been a surge in the prescription and use of HRT. These therapies aim to restore hormonal balance by supplementing or replacing deficient hormones with exogenous sources, alleviating symptoms, and improving overall health outcomes.

Rising geriatric population

The expanding geriatric population is a significant driver of market growth in various sectors, including the healthcare industry and specifically the HRT market. As the elderly population continues to grow, there is an increased prevalence of hormonal imbalances and related conditions that require medical intervention. With aging, the body undergoes natural physiological changes, including a decline in hormone production and regulation. Hormonal imbalances, including those associated with menopause in women and andropause in men, become more common. These imbalances can lead to a range of symptoms and health complications that significantly impact the quality of life for older individuals. HRT offers a solution to restore hormonal balance by supplementing or replacing deficient hormones, thereby alleviating symptoms and improving overall well-being.

Significant technological advancements in hormone delivery methods

Ongoing technological advancements are a significant driver of market growth in the field of HRT. These advancements play a crucial role in improving treatment options, enhancing patient experience, and expanding the reach of HRT. Technological innovations have led to the development of new formulations and delivery methods for HRT, such as transdermal patches, subcutaneous implants, and gel-based formulations are aiding in market expansion. Furthermore, significant advancements in the healthcare sector have facilitated the development of personalized medicine approaches in HRT. With the help of advanced diagnostic techniques, such as genetic testing and hormone level monitoring, healthcare providers can tailor HRT regimens to individual patients' specific needs, ensuring optimal hormone balance and minimizing side effects.

Hormone Replacement Therapy Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hormone replacement therapy market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product, route of administration and type of disease.

Breakup by Product:

Estrogen Replacement Therapy

Human Growth Hormone Replacement Therapy

Thyroid Replacement Therapy

Testosterone Replacement Therapy

Others

Estrogen replacement therapy dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes estrogen, human growth hormone, testosterone, thyroid replacement therapies, and others. According to the report, estrogen replacement therapy represented the largest segment.

The increasing awareness and understanding of the health risks associated with hormonal deficiencies, particularly in women, represents one of the prime factors impelling the demand for estrogen in women. Estrogen plays a vital role in various physiological processes, including bone health, cardiovascular function, and cognitive function. As women age and experience menopause, estrogen levels decrease, leading to symptoms such as hot flashes, mood swings, and increased risk of osteoporosis and cardiovascular diseases. The recognition of these risks has resulted in a higher demand for ERT as a means to alleviate symptoms and mitigate long-term health complications, creating a favorable outlook for market growth. Moreover, the rising focus on promoting quality of life and well-being among women is acting as another significant growth-inducing factor. ERT can effectively manage menopausal symptoms, enabling women to maintain an active and fulfilling lifestyle.

Breakup by Route of Administration:

Oral

Parenteral

Transdermal

Parenteral holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes oral, parenteral and transdermal. According to the report, parenteral accounted for the largest market share.

The expanding demand for parenteral HRT is propelled by the growing need for precise and controlled hormone administration. Parenteral routes, such as injections and implants, offer direct delivery of hormones into the bloodstream, bypassing the digestive system and ensuring optimal absorption. This method allows for accurate dosing and immediate effects, making it particularly beneficial for patients requiring quick symptom relief or precise hormone regulation. In addition to this, the rising preference for long-acting formulations such as depot injections or subcutaneous implants, which provide a sustained and continuous release of hormones over an extended period, eliminating the need for frequent dosing, is aiding in market expansion. Furthermore, the increasing popularity of parenteral HRT among individuals with gastrointestinal issues or malabsorption problems or patients who may have difficulties with oral hormone medications is positively impacting the market growth.

Breakup by Type of Disease:

Menopause

Hypothyroidism

Male Hypogonadism

Growth Hormone Deficiency

Others

Menopauses dominate the market

The report has provided a detailed breakup and analysis of the market based on the type of disease. This includes menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and others. According to the report, menopause represented the largest segment.

The expanding global female geriatric population is a significant factor impelling the demand for menopause-related HRT. As women age, they experience a decline in estrogen levels, leading to menopausal symptoms such as hot flashes, night sweats, and mood swings. The aging population is driving the need for effective treatments to alleviate these symptoms and improve the quality of life for menopausal women. Moreover, the growing awareness and understanding of the impact of menopause on women's health are contributing to market growth. In addition to this, the availability of diverse treatment options and formulations, including oral tablets, transdermal patches, gels, and sprays, to cater to individual preferences and needs are strengthening market growth.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest hormone replacement therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

Several factors are currently driving the North American hormone replacement therapy (HRT) market. The region is witnessing a rise in the incidences of hormone imbalance disorders, particularly among the geriatric and neonatal populations, fueling the demand for HRT as a means to address these disorders effectively. Furthermore, there is an increasing need for new treatment options that provide better safety results, which is further propelling the market growth in North America. Patients and healthcare professionals are seeking HRT products that offer improved efficacy and minimize potential side effects, thereby driving the demand for advanced therapeutic options. In addition, the region is experiencing a rise in research and development activities focused on hormone replacement products. These endeavors aim to enhance the quality and efficiency of HRT, leading to the development of innovative formulations and treatment approaches.

Competitive Landscape:

The market is characterized by the presence of several key players. These companies compete based on factors such as product portfolio, research and development capabilities, geographical presence, and marketing strategies. Prominent pharmaceutical companies hold a significant market share and play a crucial role in shaping competitive dynamics. These industry leaders leverage their extensive experience, strong distribution networks, and established brand reputation to maintain their market position. In addition to established players, there is also a presence of emerging and niche players that focus on specific segments or regions within the HRT market. These companies often emphasize innovation and develop novel treatment approaches, targeting unmet needs and offering differentiated solutions.

The market research report has provided a comprehensive analysis of the competitive landscape in the industry. Detailed profiles of all major companies have also been provided. Some of the key players include:

Abbott Laboratories

Bayer AG

Eli Lilly & Company

Roche

Hisamitsu Pharmaceutical Co. Inc.

Merck

Mylan

Novartis

Novo Nordisk

Pfizer

Recent Developments:

In February 2022, Pfizer Inc. and OPKO Health, Inc. announced the marketing authorization for the next-generation long-acting recombinant human growth hormone NGENLA.

In August 2020, Bayer, a global leader in women's healthcare, announced the acquisition of UK-based biotech company KaNDy Therapeutics Ltd. KaNDy Therapeutics Ltd. recently finished Phase IIb trials for NT-814, a non-hormonal, once-daily oral medication for treating common menopausal symptoms.

Key Questions Answered in This Report

  • 1. What was the size of the global hormone replacement therapy market in 2023?
  • 2. What is the expected growth rate of the global hormone replacement therapy market during 2024-2032?
  • 3. What are the key factors driving the global hormone replacement therapy market?
  • 4. What has been the impact of COVID-19 on the global hormone replacement therapy market?
  • 5. What is the breakup of the global hormone replacement therapy market based on the product?
  • 6. What is the breakup of the global hormone replacement therapy market based on the route of administration?
  • 7. What is the breakup of the global hormone replacement therapy market based on the type of disease?
  • 8. What are the key regions in the global hormone replacement therapy market?
  • 9. Who are the key players/companies in the global hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Price Analysis
  • 5.5 Market Breakup by Product
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Type of Disease
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Overview
    • 5.11.2 Research and Development
    • 5.11.3 Raw Material Procurement
    • 5.11.4 Manufacturing
    • 5.11.5 Marketing
    • 5.11.6 Distribution
    • 5.11.7 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Transdermal
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hypothyroidism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Male Hypogonadism
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Abbott Laboratories
    • 10.3.2 Bayer AG
    • 10.3.3 Eli Lilly & Company
    • 10.3.4 Roche
    • 10.3.5 Hisamitsu Pharmaceutical Co. Inc.
    • 10.3.6 Merck
    • 10.3.7 Mylan NV
    • 10.3.8 Novartis AG
    • 10.3.9 Novo Nordisk A/S
    • 10.3.10 Pfizer Inc.

List of Figures

  • Figure 1: Global: Hormone Replacement Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Hormone Replacement Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hormone Replacement Therapy Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Hormone Replacement Therapy Market: Breakup by Route of Administration (in %), 2023
  • Figure 5: Global: Hormone Replacement Therapy Market: Breakup by Type of Disease (in %), 2023
  • Figure 6: Global: Hormone Replacement Therapy Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Hormone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Hormone Replacement Therapy Industry: SWOT Analysis
  • Figure 9: Global: Hormone Replacement Therapy Industry: Value Chain Analysis
  • Figure 10: Global: Hormone Replacement Therapy Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Hormone Replacement Therapy (Estrogen) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Hormone Replacement Therapy (Estrogen) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Hormone Replacement Therapy (Human Growth Hormone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Hormone Replacement Therapy (Human Growth Hormone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Hormone Replacement Therapy (Thyroid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Hormone Replacement Therapy (Thyroid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Hormone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Hormone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Hormone Replacement Therapy (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Hormone Replacement Therapy (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Hormone Replacement Therapy (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Hormone Replacement Therapy (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Hormone Replacement Therapy (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Hormone Replacement Therapy (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Hormone Replacement Therapy (Transdermal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Hormone Replacement Therapy (Transdermal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Hormone Replacement Therapy (Menopause) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Hormone Replacement Therapy (Menopause) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Hormone Replacement Therapy (Hypothyroidism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Hormone Replacement Therapy (Hypothyroidism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Hormone Replacement Therapy (Male Hypogonadism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Hormone Replacement Therapy (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Hormone Replacement Therapy (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Hormone Replacement Therapy (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Europe: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Europe: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia Pacific: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia Pacific: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Middle East and Africa: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Middle East and Africa: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Latin America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Latin America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Hormone Replacement Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Hormone Replacement Therapy Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hormone Replacement Therapy Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Hormone Replacement Therapy Market Forecast: Breakup by Type of Disease (in Million US$), 2024-2032
  • Table 5: Global: Hormone Replacement Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Hormone Replacement Therapy Market: Competitive Structure
  • Table 7: Global: Hormone Replacement Therapy Market: Key Players